Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,555 | 556 | 99.9% |
| Education | $7.12 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $966.06 | 67 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $795.04 | 37 | $0 (2024) |
| Novo Nordisk Inc | $775.95 | 62 | $0 (2024) |
| Amgen Inc. | $756.86 | 45 | $0 (2024) |
| Lilly USA, LLC | $659.04 | 55 | $0 (2024) |
| ABBVIE INC. | $516.21 | 27 | $0 (2024) |
| PFIZER INC. | $471.29 | 40 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $442.10 | 35 | $0 (2024) |
| Amarin Pharma Inc. | $293.57 | 19 | $0 (2021) |
| Allergan, Inc. | $290.53 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,510 | 69 | AstraZeneca Pharmaceuticals LP ($290.37) |
| 2023 | $1,260 | 60 | GlaxoSmithKline, LLC. ($174.48) |
| 2022 | $534.40 | 32 | GlaxoSmithKline, LLC. ($91.82) |
| 2021 | $920.17 | 63 | Novo Nordisk Inc ($142.58) |
| 2020 | $1,043 | 70 | Amgen Inc. ($152.48) |
| 2019 | $1,763 | 139 | Amgen Inc. ($211.37) |
| 2018 | $1,162 | 103 | Novo Nordisk Inc ($225.16) |
| 2017 | $368.42 | 21 | Amgen Inc. ($138.60) |
All Payment Transactions
557 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: VACCINE | ||||||
| 11/21/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Diabetes | ||||||
| 11/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Neurology | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.60 | General |
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.79 | General |
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,199 | 1,512 | $265,296 | $101,391 |
| 2022 | 11 | 1,051 | 1,317 | $221,115 | $93,128 |
| 2021 | 11 | 927 | 1,167 | $125,737 | $77,541 |
| 2020 | 14 | 689 | 953 | $105,225 | $60,522 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 258 | 491 | $127,870 | $42,450 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 203 | 203 | $53,668 | $26,309 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 224 | $41,279 | $12,740 | 30.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 51 | 53 | $7,608 | $3,802 | 50.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 197 | 197 | $7,559 | $3,706 | 49.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 183 | 183 | $7,022 | $3,442 | 49.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,382 | $2,147 | 49.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 29 | 30 | $2,936 | $1,827 | 62.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 56 | $3,532 | $1,731 | 49.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,719 | $1,320 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,107 | $1,251 | 30.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $1,181 | $462.77 | 39.2% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 11 | $357.82 | $166.14 | 46.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 11 | $76.56 | $37.51 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 381 | $94,249 | $35,318 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 166 | 166 | $40,737 | $22,029 | 54.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 179 | 277 | $45,791 | $17,105 | 37.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 31 | 31 | $10,615 | $5,227 | 49.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 182 | 182 | $6,581 | $3,522 | 53.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 150 | 150 | $5,310 | $2,848 | 53.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 32 | 32 | $4,066 | $2,187 | 53.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $5,056 | $1,566 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,419 | $1,471 | 33.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 36 | $2,142 | $1,092 | 51.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 24 | 25 | $2,150 | $762.65 | 35.5% |
About Dr. Robert Ondash, M.D
Dr. Robert Ondash, M.D is a Internal Medicine healthcare provider based in West Lake Hills, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053320069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ondash, M.D has received a total of $8,562 in payments from pharmaceutical and medical device companies, with $1,510 received in 2024. These payments were reported across 557 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($8,555).
As a Medicare-enrolled provider, Ondash has provided services to 3,866 Medicare beneficiaries, totaling 4,949 services with total Medicare billing of $332,581. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location West Lake Hills, TX
- Active Since 08/07/2006
- Last Updated 05/18/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053320069
Products in Payments
- TRELEGY ELLIPTA (Drug) $653.66
- Ozempic (Drug) $341.31
- Repatha (Biological) $315.39
- Vascepa (Drug) $293.57
- Aimovig (Biological) $280.42
- JARDIANCE (Drug) $273.46
- FARXIGA (Drug) $264.80
- Trintellix (Drug) $259.38
- BREZTRI (Drug) $255.33
- TRULICITY (Drug) $253.50
- UBRELVY (Drug) $219.75
- Rybelsus (Drug) $189.96
- LINZESS (Drug) $187.06
- CHANTIX (Drug) $182.24
- Otezla (Drug) $180.36
- Victoza (Drug) $161.98
- MYRBETRIQ (Drug) $156.55
- VRAYLAR (Drug) $152.21
- TRINTELLIX (Drug) $147.22
- REXULTI (Drug) $139.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Lake Hills
Rani Das, M.d, M.D
Internal Medicine — Payments: $18,311
Raymond Paxton, Md, MD
Internal Medicine — Payments: $6,051
Lakshmi Tenneti, Md, MD
Internal Medicine — Payments: $3,264
Hayan Yacoub, Md, MD
Internal Medicine — Payments: $3,152
Alberto Brizuela Ducharne, Md, MD
Internal Medicine — Payments: $2,874
Rehana Becker, Md, MD
Internal Medicine — Payments: $2,086